Dandel Michael
German Centre for Heart and Circulatory Research (DZHK), Partner Site Berlin, Berlin, Germany.
Cardiovasc Diagn Ther. 2024 Feb 15;14(1):193-222. doi: 10.21037/cdt-23-380. Epub 2024 Feb 1.
Regardless of whether pulmonary hypertension (PH) results from increased pulmonary venous pressure in left-sided heart diseases or from vascular remodeling and/or obstructions in pre-capillary pulmonary vessels, overload-induced right ventricular (RV) dysfunction and its final transition into right-sided heart failure is a major cause of death in PH patients. Being particularly suited for non-invasive monitoring of the right-sided heart, echocardiography has become a useful tool for optimizing the therapeutic decision-making and evaluation of therapy results in PH. The review provides an updated overview on the pathophysiological insights of heart-lung interactions in PH of different etiology, as well as on the diagnostic and prognostic value of echocardiography for monitoring RV responses to pressure overload. The article focuses particularly on the usefulness of echocardiography for predicting life-threatening aggravation of RV dysfunction in transplant candidates with precapillary PH, as well as for preoperative prediction of post-operative RV failure in patients with primary end-stage left ventricular (LV) failure necessitating heart transplantation or a LV assist device implantation. In transplant candidates with refractory pulmonary arterial hypertension, a timely prediction of impending RV decompensation can contribute to reduce both the mortality risk on the transplant list and the early post-transplant complications caused by severe RV dysfunction, and also to avoid combined heart-lung transplantation. The review also focuses on the usefulness of echocardiography for monitoring the right-sided heart in patients with acute respiratory distress syndrome, particularly in those with refractory respiratory failure requiring extracorporeal membrane oxygenation support. Given the pathophysiologic particularity of severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection to be associated with a high incidence of thrombotic microangiopathy-induced increase in the pulmonary resistance, echocardiography can improve the selection of temporary mechanical cardio-respiratory support strategies and can therefore contribute to the reduction of mortality rates. On the whole, the review aims to provide a theoretical and practical basis for those who are or intend in the future to be engaged in this highly demanding field.
无论肺动脉高压(PH)是由左心疾病导致的肺静脉压力升高引起,还是由毛细血管前肺血管的血管重塑和/或阻塞引起,超负荷诱导的右心室(RV)功能障碍及其最终转变为右心衰竭都是PH患者的主要死因。超声心动图特别适合对右心进行无创监测,已成为优化PH治疗决策和评估治疗效果的有用工具。本综述提供了关于不同病因的PH中心肺相互作用的病理生理学见解的最新概述,以及超声心动图对监测RV对压力超负荷反应的诊断和预后价值。本文特别关注超声心动图在预测毛细血管前PH移植候选者中危及生命的RV功能障碍加重方面的有用性,以及在需要心脏移植或植入左心室辅助装置的原发性终末期左心室(LV)衰竭患者中术前预测术后RV衰竭的有用性。在难治性肺动脉高压的移植候选者中,及时预测即将发生的RV失代偿有助于降低移植名单上的死亡风险和由严重RV功能障碍引起的早期移植后并发症,还可避免心肺联合移植。本综述还关注超声心动图在监测急性呼吸窘迫综合征患者右心方面的有用性,特别是在那些需要体外膜肺氧合支持的难治性呼吸衰竭患者中。鉴于严重急性呼吸综合征冠状病毒(SARS-CoV-2)感染的病理生理特殊性与血栓性微血管病导致的肺阻力增加的高发生率相关,超声心动图可改善临时机械心肺支持策略的选择,从而有助于降低死亡率。总体而言,本综述旨在为那些目前或未来打算从事这一高要求领域工作的人员提供理论和实践基础。